Liver Fibrosis Is Associated with Poorer Overall Survival and Higher Recurrence Rate in Patients with Cholangiocarcinoma
Digestive Surgery · 2024
DOI: 10.1159/000535733 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Surgery, 2024. Verfasst von Marcella Steffani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany, marcella.steffani@tum.de. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Carcinoma, Hepatocellular, Liver Neoplasms, Bile Duct Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Introduction
Cholangiocarcinoma is the second most common primary liver tumour worldwide with an increasing incidence in recent decades. While the effects of fibrosis on hepatocellular carcinoma have been widely demonstrated, the impact on cholangiocarcinoma remains unclear. The aim of this study was to evaluate the impact of liver fibrosis on overall survival (OS) and disease-free survival (DFS) in patients who have undergone liver resection for cholangiocarcinoma.
Methods
Eighty patients with cholangiocarcinoma who underwent curatively intended liver surgery between January 2007 and December 2020 were included in this retrospective single-centre study. Clinical and histopathological features were analysed. The primary endpoint was cause-specific survival. Secondary endpoints were DFS and identification of prognostic factors.
Results
The present study shows that the median OS is significantly reduced in patients with fibrosis (p < 0.001). The median OS in patients with fibrosis was three times shorter than in the group without fibrosis. In addition, a significantly shorter DFS was observed in patients with fibrosis (p < 0.002). Multivariate analysis showed that fibrosis is the strongest independent factor with a negative impact on OS and DFS.
Conclusion
Liver fibrosis has a significant impact on OS and DFS in patients with cholangiocarcinoma. Patients with known liver fibrosis require thorough perioperative care and postoperative follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany, marcella.steffani@tum.de.
- Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
Zitieren
APA
Steffani, M., Nitsche, U., Ollesky, J., Kaufmann, B., Schulze, S., Novotny, A., Friess, H., Hüser, N., Stoess, C., & Hartmann, D. (2024). Liver Fibrosis Is Associated with Poorer Overall Survival and Higher Recurrence Rate in Patients with Cholangiocarcinoma. Digestive Surgery. https://doi.org/10.1159/000535733
Vancouver
Steffani M, Nitsche U, Ollesky J, Kaufmann B, Schulze S, Novotny A, et al. Liver Fibrosis Is Associated with Poorer Overall Survival and Higher Recurrence Rate in Patients with Cholangiocarcinoma. Digestive Surgery. 2024. doi:10.1159/000535733
BibTeX
@article{Steffani2024,
author = {Steffani, Marcella and Nitsche, Ulrich and Ollesky, Johanna and Kaufmann, Benedikt and Schulze, Sarah and Novotny, Alexander and Friess, Helmut and Hüser, Norbert and Stoess, Christian and Hartmann, Daniel},
title = {Liver Fibrosis Is Associated with Poorer Overall Survival and Higher Recurrence Rate in Patients with Cholangiocarcinoma},
journal = {Digestive Surgery},
year = {2024},
doi = {10.1159/000535733}
}
EUVIMED